![Primary Results From AMEERA-5](https://oncodaily.com/pub/uploads/2024/06/journal-of-clinical-oncology-logo-1.png)
Photo taken from pc3i.upenn.edu
Jun 22, 2024, 13:36
Primary Results From AMEERA-5
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X:
“Amcenestrant Plus Palbociclib vs Letrozole Plus Palbociclib in ER–Positive, HER 2–Negative Advanced BC: Primary Results From AMEERA-5
PFS-HR:1.2
This study was discontinued on the recommendation of the data monitoring committee.”
Read further.
Source: Yakup Ergün/X